IGF-1R(胰岛素样生长因子 1 受体)是一种受体酪氨酸激酶,与配体 IGF-1 或 IGF-2 结合后被激活,从而导致正常细胞和癌细胞的生长、存活和迁移。
IGF-1R 可以启动 PI3K/AKT/mTOR 信号和 Ras/Raf/MEK/MAPK 通路的激活,从而激活多种转录因子(如 ELK-1、CREB 和 AP-1)来调节细胞增殖、存活、分化、运动、侵袭和血管生成。IGF-1R 过表达或 IGF-1R 激酶活性增加与多种人类癌症有关,因此 IGF-1R 被广泛认为是癌症治疗的一个非常有希望的靶点。
IGF-1R (Insulin-like growth factor 1 receptor), a receptor tyrosine kinase, is activated upon binding to the ligands IGF-1 or IGF-2 leading to cell growth, survival and migration of both normal and cancerous cells.
IGF-1R can initiate the activation of the PI3K/AKT/mTOR signaling and Ras/Raf/MEK/MAPK pathways resulting in the activation of multiple transcription factors such as ELK-1, CREB and AP-1 to modulate cell proliferation, survival, differentiation, motility, invasion and angiogenesis. IGF-1R overexpression or increased IGF-1R kinase activity is associated with a broad range of human cancers and therefore the IGF-1R is widely considered as a very promising target for cancer treatment.
IGF-1R modulator 1 (Example 5) 是一种 IGF-1R 调节剂,对 FGFR1、IGF1R、TrkA 和 TrkB 的 EC50 分别为 0.29 μM、0.25 μM、0.34 μM 和 0.39 μM,可用于研究以神经营养因子和/或其他营养因子信号传导受损为特征的疾病,例如阿尔茨海默病。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号